Clinical Trial Update: Tirofiban in Stenting for Long Coronary Lesion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tirofiban during stenting for long coronary lesions in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• tirofiban (tirofiban)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED